Recombinant thrombomodulin - PAION

Drug Profile

Recombinant thrombomodulin - PAION

Alternative Names: Solulin

Latest Information Update: 11 Feb 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Berlex Biosciences
  • Developer PAION
  • Class Anti-inflammatories; Anticoagulants; Peptides; Platelet membrane glycoproteins; Recombinant proteins
  • Mechanism of Action Thrombin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Suspended Haemophilia; Stroke; Thrombosis

Most Recent Events

  • 11 Feb 2015 Suspended - Phase-I for Haemophilia (Adjunctive treatment) in Germany (IV) prior to February 2015
  • 11 Feb 2015 Suspended - Phase-I for Stroke (In volunteers) in Germany (IV) prior to February 2015
  • 11 Feb 2015 Suspended - Phase-I for Thrombosis (In volunteers) in Germany (IV) prior to February 2015
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top